Do triple test results predict risk for neonatal hyperbilirubinemia?

Area of Science:

• Perinatal medicine
• Neonatology
• Biochemistry

Background:

• Neonatal jaundice is a common condition requiring medical attention.
• Significant hyperbilirubinemia is defined as >17 mg/dL in term infants.
• Neurological damage from severe jaundice is a critical concern.

Purpose of the Study:

• To investigate the association between second-trimester serum markers and neonatal severe hyperbilirubinemia.
• To identify predictive markers for neonatal hyperbilirubinemia to prevent adverse outcomes.

Main Methods:

• A cohort of 1372 pregnant women undergoing triple testing was studied.
• The primary outcome measured was neonatal significant hyperbilirubinemia.
• Data analysis focused on correlations between triple test markers and hyperbilirubinemia, excluding Rh incompatibility.

Main Results:

• Low estriol (E3) levels were significantly associated with neonatal hyperbilirubinemia.
• Ratios of AFP/E3 and hCG/E3 were identified as strong predictors.
• Maternal factors like pregnancy history or health issues did not influence the risk.

Conclusions:

• Low E3 levels in the triple test can serve as a predictive marker for neonatal hyperbilirubinemia.
• This predictive approach may aid in early intervention to prevent neurological complications.
• The cost-effectiveness of this method in developing countries warrants consideration.